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Abstract
Background: Accumulating evidence is supporting the protective effect of whole grains against several chronic
diseases. Simultaneously, our knowledge is increasing on the impact of gut microbiota on our health and on how
diet can modify the composition of our bacterial cohabitants. Herein, we studied C57BL/6 J mice fed with diets
enriched with rye bran and wheat aleurone, conventional and germ-free C57BL/6NTac mice on a basal diet, and
the colonic fermentation of rye bran in an in vitro model of the human gastrointestinal system. We performed 16S
rRNA gene sequencing and metabolomics on the study samples to determine the effect of bran-enriched diets on
the gut microbial composition and the potential contribution of microbiota to the metabolism of a novel group of
betainized compounds.
Results: The bran-enriched study diets elevated the levels of betainized compounds in the colon contents of
C57BL/6 J mice. The composition of microbiota changed, and the bran-enriched diets induced an increase in the
relative abundance of several bacterial taxa, including Akkermansia, Bifidobacterium, Coriobacteriaceae, Lactobacillus,
Parasutterella, and Ruminococcus, many of which are associated with improved health status or the metabolism of
plant-based molecules. The levels of betainized compounds in the gut tissues of germ-free mice were significantly
lower compared to conventional mice. In the in vitro model of the human gut, the production of betainized
compounds was observed throughout the incubation, while the levels of glycine betaine decreased. In cereal
samples, only low levels or trace amounts of other betaines than glycine betaine were observed.
Conclusions: Our findings provide evidence that the bacterial taxa increased in relative abundance by the bran-
based diet are also involved in the metabolism of glycine betaine into other betainized compounds, adding
another potential compound group acting as a mediator of the synergistic metabolic effect of diet and colonic
microbiota.
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Background
The past 15 years of research has shown that the modula-
tion of colonic microbial composition by diet [1, 2] is an
essential contributor to human health [3–5]. Correspond-
ingly, the microbiota-mediated conversions of a broad
array of dietary compounds entering the human body and
their impact on the endogenous metabolism thereafter
have consequences for health [6–9]. In particular, the role
of dietary fibre in shaping the microbiota has become evi-
dent, as the low consumption of fibre-rich foods in West-
ern diets has been linked to reduced microbial diversity
[10, 11], whereas diets high in dietary plant-based fibre
have been associated with increased diversity and the rise
of distinct microbial populations [10, 12].
Epidemiological evidence suggests that a diet rich in
whole grains reduces the risk of chronic diseases, such
as cardiovascular disease, type 2 diabetes, and certain
types of cancer [13–16]. In addition, prospective cohort
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studies have shown that whole grain intake is strongly
associated with a linear dose-dependent reduction in the
risk of all-cause mortality [17]. Numerous controlled
clinical trials have similarly demonstrated the alleviation
of chronic disease risk factors [18–22]; however, some
studies concluded no improvement in clinical markers,
possibly because of differences in the study settings,
populations, and defining what is considered as whole-
grain food [23–25]. Despite the strong evidence for the
beneficial health effects of whole grains, the underlying
molecular mechanisms responsible for these effects have
remained elusive. Most likely, they are related to the
presence of the nutrient-dense bran compartment, rich
in fibre, micronutrients, and phytochemicals, retained in
whole-grain foods [26–28].
Betaines are zwitterionic compounds with a cationic
onium atom, such as quaternary ammonium, that is not
bearing any hydrogens. Originally, the term was limited
to glycine betaine (N,N,N-trimethylglycine), which was
first discovered from sugar beet (Beta vulgaris L.) in the
nineteenth century, hence giving the name for this com-
pound group. Several betaines are derived from amino
acids, and at least 25 such compounds have been de-
tected thus far in living organisms, such as marine algae
[29, 30]. The research on the potential health effects of
betaines has been mostly concentrated on glycine beta-
ine, as it has an osmoprotective role, protecting the cell
from dehydration, osmotic stress, extreme temperatures,
and high salinity [31]. In addition, it participates as a
methyl donor in transmethylation reactions of the me-
thionine cycle, which in turn occurs in several vital
mammalian metabolic processes, such as the transform-
ation of homocysteine into methionine [32]. Trigonel-
line, the N-methylated form of niacin, has been
characterized as a plant estrogen [33] and has shown
antibacterial (anti-cariogenic) effects in vitro [34]. We
have recently conducted a series of investigations and
characterized several novel betaines in mice and humans
following the consumption of diets rich in whole grains
[35, 36]. We also showed that one of the novel betai-
nized compounds, 5-aminovaleric acid betaine (5-
AVAB), which accumulated in metabolically active tis-
sues, such as heart and brown adipose tissue (BAT) in
mice, can influence mitochondrial energy metabolism in
cultured mouse cardiomyocytes by blocking β-oxidation
of fatty acids similarly to meldonium, a drug used for is-
chemia [35, 37]. However, the physiological significance
of betaines other than glycine betaine and their relation
to maintaining health remains unknown.
Given that the knowledge of betaine metabolism is
limited, the aim of this study was to investigate whether
colonic microbiota contributes to betaine metabolism by
feeding mice with bran-enriched diets, analyzing tissues
from conventional and germ-free mice, and performing
colonic fermentation of bran in an in vitro model of the
human gastrointestinal system. We hypothesized that a
(1) diet containing cereal fibre will have an impact on
the gut microbial composition and that (2) gut micro-
biota transforms glycine betaine into other amino acid-
derived betaines when the compound reaches the colon
within the fibre matrix.
Results
Bran-enriched feed causes elevation of betainized
compounds in colonic content of mice
We have shown earlier that the inclusion of bran in the
diet of mice caused elevation of betainized compounds
in urine [36] as well as plasma and tissues [35] of
C57BL/6 J mice fed with bran-enriched diets. Herein, we
examined colonic contents collected from the same
mouse strain fed with similar bran-enriched diets. We
used two different parts of whole-grain cereals, rye bran
and wheat aleurone (the innermost layer of wheat bran),
both of which are abundant in dietary fibre and bioactive
compounds [38, 39], such as polyphenols which are
known to interact with gut microbiota. Moreover, these
two cereal fractions were bioprocessed in order to
hydrolyze their dietary fibre and release bioactive com-
pounds, improving their bioavailability in the intestinal
tract.
We found that the concentrations of eight betai-
nized compounds, namely 5-aminovaleric acid beta-
ine (5-AVAB), alanine betaine, phenylalanine
betaine, pipecolic acid betaine, proline betaine, tri-
gonelline, tryptophan betaine, and valine betaine,
were significantly elevated in the colon content of
animals fed with the bran-enriched diets compared
to animals fed with the high-fat (HF) control diet
(Fig. 1a). Although the majority of the betainized
compounds were found also in the samples from
mice on the HF diet, pipecolic acid betaine, phenyl-
alanine betaine, and tryptophan betaine were only
found in the bran-fed groups, with the latter two
compounds being restricted to the rye bran-
enriched groups (Fig. 1a). Glycine betaine levels
were found to be similar between the animals fed
with bran-enriched diets and control diets despite
the fact that the bran-enriched diets provide an
additional source of glycine betaine.
Difference in composition of microbiota in mice receiving
bran-enriched diets
A qualitative analysis was performed on the microbial com-
position from the caecal contents of the C57BL/6 J mice,
using 16S ribosomal RNA gene sequencing. There were not-
able differences between the groups receiving the bran-
enriched diets and the control groups that included mice on
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high-fat diet (HF), low-fat diet (LF), or on a high-fat diet
switched to low-fat diet after 9 weeks (HFLF) (Fig. 1b). The
overall difference in the microbial composition between the
bran-enriched diet groups and controls was more evident
than the differences between the control groups (Additional
file 2: Figure S1). Of the control diets, the mice fed with the
LF diet had the closest proximity to mice fed with the bran-
enriched diet in the PCA (Fig. 1b). High within-group vari-
ability in the bacterial composition was also evident in the
analysis. We performed ANOSIM of weighted and un-
weighted UniFrac distances to further confirm the difference
between the control and treatment diets (weighted R =
0.231, unweighted R = 0.697, p < 0.001 for both tests) and
between all diets (weighted R = 0.321, unweighted R =
0.556, p < 0.001 for both tests).
Redundancy analysis (RDA) and univariate fold change
analysis revealed that certain microbial groups, including
Akkermansia, Bacteroides, Bifidobacterium, an unclassified
genus within family Coriobacteriaceae, Enterorhabdus,
Lactobacillus, Parasutterella, and Ruminococcus, were
higher in relative abundance in the groups receiving the
bran-enriched diet (Figs. 2 and 3, Additional file 3: Figure
S2). In contrast, Alistipes, an unclassified genus within the
order Clostridiales, Desulfovibrio, Mucispirillum, Odoribac-
ter, and Rikenella were higher in the control diets. The rye
bran-enriched diets caused a higher increase in the relative
abundance of several bacterial taxa, including Alistipes,
Desulfovibrio, Lactococcus, and unclassified genera within
families Lachnospiraceae and Peptococcaceae, when com-
pared to the wheat aleurone-enriched diets. Bran biopro-
cessing, which enhances the bioavailability of fibre-bound
compounds [40], increased the relative abundance of Allo-
baculum and Parabacteroides and decreased the relative
abundance of Bifidobacterium, an unclassified genus within
family Lachnospiraceae, and Lactobacillus in mice receiving
bioprocessed wheat aleurone. In mice receiving either un-
processed or bioprocessed rye bran, there were no statisti-
cally significant differences in the relative bacterial
abundances. A few taxa were higher in relative abundance
only in a certain diet group, such as Roseburia in the HF
diet group and Allobaculum and Parasutterella in the
group receiving a bioprocessed wheat aleurone-enriched
diet (A4) (Fig. 3, Additional file 3: Figure S2). Unclassified
genera within families Prevotellaceae and Erysipelotricha-
ceae were only found from the caecal contents of one study
animal that had received the diet enriched with unpro-
cessed rye bran (R1).
We also measured the alpha diversity of the caecal
microbiota in the C57BL/6 J mice to assess the impact of
diet on the richness and diversity of the microbial popu-
lation. The diversity was significantly lower in the wheat
aleurone-based A1 and A4 diets compared to the rye-
enriched R1 and R2 diets (Shannon’s index and Simpson
diversity index) and compared to the HF diet (only for
Fig. 1 a Betaine levels in the colon contents of mice fed with bran-enriched diets. HF high fat (control) diet, R1 native rye bran, R2 bioprocessed
rye bran, A1 native wheat aleurone, A4 ground and bioprocessed wheat aleurone. The asterisks signify the p value from one-way ANOVA (HF
compared to all bran-enriched diets). *p < 0.05; **p < 0.01; ***p < 0.001. b Principal component analysis (PCA) of the microbial composition from
the caecal contents of mice fed with a high-fat control diet (HF), alternating high-fat low-fat control diet (HFLF), low-fat control diet (LF), wheat
aleurone-enriched feed (A1 and A4), and rye bran-enriched feed (R1 and R2)
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Shannon’s index) (Fig. 4). No significant difference in di-
versity was observed between the control and rye-
enriched diets.
Correlation between gut microbiota and individual
betainized compounds
After finding marked differences in the content of betai-
nized compounds as well as the microbial composition
after the consumption of bran-enriched feed, we ana-
lyzed whether there were any specific correlations be-
tween the microbial taxa and betainized compounds.
We observed that the increment of the bacterial taxa as-
sociated with the bran-enriched diets was associated
with the levels of betainized compounds, including 5-
AVAB, proline betaine, and valine betaine, in the caecal
tissue of mice (Figs. 2 and 3). However, glycine betaine
levels did not clearly show any association with any of
the treatment groups and were not positively associated
with any bacterial taxa. On the other hand, a strong
positive correlation was found between 5-AVAB and
Bifidobacterium, and strong inverse correlations were
observed between 5-AVAB and 18 different bacterial
taxa, including Alistipes, unclassified genus within the
Clostridiales, Desulfovibrio, Mucispirillum, Odoribacter,
and Rikenella, with decreased relative abundance in the
bran-enriched diet groups (Fig. 3).
Levels of betainized compounds in germ-free mice
Based on the correlation between betainized compounds
and gut microbial taxa, we hypothesized that the colonic
microbiota could be the metabolic source for the produc-
tion of the betainized compounds. We examined 13 differ-
ent tissue samples from conventional murine pathogen-free
(MPF) and germ-free (GF) C57BL/6NTac male mice to
support the study hypothesis. The study showed that the
levels of glycine betaine were not altered greatly between
the mice groups, while the levels of several other betaines,
including alanine betaine and 5-AVAB, a betainized metab-
olite that we characterized recently [37], were significantly
lower in the duodenal, jejunal, ileal, and caecal tissues of
the germ-free mice compared to conventional mice (Fig.
5a, Additional file 4: Figure S3). In both mice groups, the
plasma levels of 5-AVAB were low, whereas its levels in
heart, muscle, and BAT were relatively high. Trimethyla-
mine N-oxide (TMAO), a betainized metabolite with mi-
crobial origin [41], was used as a reference compound to
verify the germ-free status of the mice. TMAO was found
only as a trace in the tissues of the germ-free mice.
Microbiota contributes to the production of betainized
compounds in a human gut model
After unveiling the potential contribution of micro-
biota in betaine metabolism, we hypothesized that
gut microbiota may transform glycine betaine into
other betainized compounds once it reaches the
colon by using e.g. fibre matrix as a carrying vehicle.
Therefore, we incubated unprocessed and biopro-
cessed rye bran in an in vitro model of the human
gastrointestinal tract with faecal microbiota pooled
from volunteer donors to elucidate the time-
Fig. 2 Redundancy analysis (RDA) of the identified betainized compounds (dark grey arrows), diet groups (coloured nodes), and genus-level
relative bacterial abundances (purple arrows) in the colonic contents of the studied mice. The microbial composition and the diet groups are
used as explanatory variables, together accounting for 93% of the variation in the metabolite levels
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dependent metabolism of the compounds and to as-
sess whether the observations in mice can be applied
to humans. Investigation of samples from the in
vitro model of human colonic fermentation showed
that similar metabolic conversions can occur in the
human gut (Fig. 5b); upon addition of native or bio-
processed rye bran fractions, betainized compounds
were produced throughout the 24-h in vitro incuba-
tion, whereas the levels of the betainized compounds
in the faecal background control samples decreased
after 4 to 6 h. In contrast to other betainized com-
pounds, glycine betaine was the only compound to
have its level decreased during the 24-h incubation
(Fig. 5b).
Fig. 3 Heat map representation of the identified 48 bacterial taxa and their relation to the identified betaine compounds and the diets. Left:
correlations between the relative abundance of microbial taxa in the caecal contents of mice and betaine compounds in the caecal tissue
(Pearson correlation, p < 0.05 marked with a circle) in HF and bran-enriched diet groups. Centre: comparison of all diet groups (Kruskal–Wallis
one-way ANOVA, p < 0.05 marked with a circle) and fold changes of the relative abundances of microbial taxa between the bran-enriched
treatment diets and the control diets, between the rye bran and wheat aleurone-enriched diets, and between the diets containing unprocessed
and bioprocessed rye bran or wheat aleurone (Mann–Whitney U test, p < 0.05 marked with a circle). Right: normalized average bacterial
abundances in each diet group
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Content of betainized compounds in whole-grain breads
Whole grains are a main source of glycine betaine in the
Western diet [42]. We have earlier shown that the levels of
other betainized compounds were also elevated after the
consumption of diets rich in whole grains or cereal bran in
humans and mice [35, 36, 43]. Therefore, we examined
wheat and rye samples (n = 10, prepared at VTT Technical
Research Centre of Finland Ltd.) containing processed or
whole-grain flour, including rye and wheat flour and breads
baked with or without sourdough fermentation. The pur-
pose herein was to find out which betainized compounds
other than glycine betaine could be originated from bread.
In addition to glycine betaine, relatively low levels of trigo-
nelline, valine betaine, proline betaine, and nine other beta-
ines were found in the bread samples, and their levels were
depending on the cereal species and whole grain content
(Additional file 5: Figure S4). 5-AVAB, phenylalanine beta-
ine, and tryptophan betaine are noteworthy because they
were not detected from the whole-grain bread samples con-
taining the bran fractions (Additional file 1: Table S1), indi-
cating they may be synthesized by microbiota after the
ingestion of the bran-enriched diet. Pipecolic acid betaine
was nearly absent from all the wheat samples, whereas iso-
leucine betaine was mainly found in whole-grain wheat
bread. Trigonelline was present in higher levels in the flour
samples compared to the bread samples, indicating the ef-
fect of the baking process. Of the identified betaines, histi-
dine betaine, alanine betaine, isoleucine betaine, and 4-
aminobutyric acid betaine have not previously been reported
from cereals.
Discussion
In this study, we observed how the bran-enriched diets
elevated the levels of betainized compounds in the
colonic content and caecal tissues of mice and altered
the gut microbial composition. These results were sup-
ported by the low content or lack of betainized com-
pounds (other than glycine betaine) in the studied
whole-grain breads, the decreased levels of the same
compounds in the gut tissues of germ-free mice com-
pared to conventional mice, and the production of the
compounds in an in vitro model of the human gut.
The bran-enriched diets had a pronounced effect on the
composition of microbiota in the mice and showed a
strong association with an increased abundance of several
microbial taxa, including Akkermansia, Bacteroides, Bifi-
dobacterium, an uncharacterized genus within the Corio-
bacteriaceae, Enterorhabdus, Lactobacillus, Parasutterella,
and Ruminococcus, all of which have previously been asso-
ciated with an improved metabolic status. Among them,
the most well-known bacteria in terms of human health
are bifidobacteria and lactobacilli, which are well-
recognized as major contributors to improved gut and
overall health [44] and have previously been associated
with whole-grain wheat intake [25]. Akkermansia mucini-
phila, the sole characterized representative of its phylum
in mammalian gut environments, was strongly associated
with the bran-enriched diets in our study (Fig. 3) and has
previously been shown to be related to decreased fasting
glucose and plasma triglycerides in a human intervention
study involving a calorie-restricted diet [45]. Similarly, an
increase in Akkermansia population and metabolic im-
provements were observed in mice fed with a high-fat diet
containing whole-grain barley [46] and cranberry extract
[47]. However, the genus is also increased in abundance
among multiple sclerosis patients, suggesting that it may
have a role in (or increase as a consequence of) the patho-
genesis of autoimmune diseases [48]. Members of the
Fig. 4 Alpha diversity of the caecal microbiota in the C57BL/6 J mice on the different control and treatment diets, measured according to
Shannon’s index (left) and Simpson diversity index (right)
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family Coriobacteriaceae carry out conversions of bile
salts, steroids and polyphenols, and are involved in the
metabolism of amino acids, nitrogen cycling, and the pro-
duction of ammonia [49]. This suggests that these bacteria
could partly be responsible for the production of amino
acid-derived betaines, as they were positively correlated
with some of the identified betaines in the current study.
Coriobacteriaceae are associated with resistance to obesity
and liver pathologies during the consumption of a high-fat
diet [50]. Enterorhabdus, a genus within the Coriobacter-
iaceae and associated with bran-enriched diets in this
study, was shown to be specific to microbiota in lean ani-
mals [50]. Some genera within Coriobacteriaceae may be
involved in the development of various pathologies, in-
cluding infections outside of the GI tract and tumorous
growths, indicating that the family should be considered
as pathobionts (potentially pathogenic commensal bac-
teria) [49]. Ruminococcus species, such as R. bromii, are
key microorganisms in the degradation of resistant starch
[51], which likely explains their increased relative abun-
dance in the bran-enriched diet groups in this study. In-
creased abundance of the genus Parasutterella, which
Fig. 5 a Glycine betaine, 5-AVAB, alanine betaine, and TMAO levels in tissue samples of GF and MPF mice (mean ± 1 SD). Caecal tissue, the main
site of gut microbial metabolism in mice, is highlighted. Mann–Whitney U test: *p < 0.05; **p < 0.01; ***p < 0.001. b Betaine levels in the in vitro
24-h fermentation model with human microbiota, incubated with rye bran fractions (mean ± 1 SD). R1 native rye bran, R2 bioprocessed rye bran,
FBL faecal blank
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increased especially after the A4 diet (enriched with bio-
processed wheat aleurone), was previously shown to be in-
versely associated with a high-fat diet in mice [52].
However, this genus was also found to be associated with
certain pathogenic conditions, such as irritable bowel syn-
drome [53]. Bacteroides were increased in their relative
abundance after the consumption of bran-enriched diets;
they are a predominant bacterial group with health-
promoting properties, such as the downregulation of in-
flammatory biomarkers [54]. Nevertheless, their increased
abundance has also been associated with type I diabetes
and celiac disease, and some Bacteroides species (e.g. B.
ovatus) have been positively correlated with gastrointes-
tinal dysbiosis and Crohn’s disease [54].
In contrast, the bran-enriched diets reduced the rela-
tive abundance of several bacterial taxa that have earlier
been associated with adverse effects in the gut and over-
all health. Alistipes was positively associated with frailty
in the elderly in a study by Claesson et al. [55]. Desulfo-
vibrio species were found to be associated with regres-
sive autism [56] and ulcerative colitis [57] and can be
potentially harmful if their abundance in the gut is in-
creased. It has been shown that Rikenella and Odoribac-
ter were exclusively present in the gut of type 2 diabetic
(db/db) mice when compared to healthy lean mice [58].
In a recent animal study, Song et al. showed that Mucis-
pirillum, Desulfovibrio, and Odoribacter were strongly
correlating with genes overexpressed in colitis-associated
cancer [59]. Overall, although several microbial groups
have been associated with either beneficial metabolic
status or disease, much of the reported results are con-
troversial. We still do not fully understand the impact of
individual bacterial species and strains on human health,
which is also affected by the whole microbial community
and the physiological and nutritional status of the host.
The cereal species seems to have an impact both on the
quality and quantity of the gut microbiota, as evidenced
by the lower alpha diversity in the caecal microbiota of
the C57BL/6 J mice receiving wheat aleurone-enriched di-
ets compared to other diets and the difference in the rela-
tive abundance of certain bacterial genera between the rye
bran and wheat aleurone-enriched diets. Bran bioproces-
sing releases high amounts of phenolic compounds from
the fibre matrix [40], which may be already absorbed in
the small intestine and thus not reach the site of microbial
fermentation, where they could be used as a substrate by
certain microbes (e.g. Bifidobacterium) and thus promote
their growth [60]. This may explain why Lactobacillus and
Bifidobacterium, known to ferment insoluble dietary fibre,
had lower relative abundance in mice receiving biopro-
cessed wheat aleurone. Although sourdough fermentation
with Lactobacillus species was used in some of the cereal
samples analyzed for betaine levels, it only had a minor ef-
fect in the levels of betainized compounds, including
glycine betaine. The low levels or lack of betainized com-
pounds, apart from glycine betaine, in all the studied
cereal samples indicates that their metabolism mostly oc-
curs after ingestion.
Glycine betaine is the predominant betainized com-
pound in cereal grains, and thus we expected to observe
high levels of the compound in the gut contents of mice
and in vitro human colonic model promoted by the bran-
enriched diets. However, the addition of bran in the diet
did not considerably increase the level of glycine betaine
in the colon contents of mice. In contrast, the levels of
alanine betaine and valine betaine, which are present in
relatively small amounts in bran, and 5-aminovaleric acid
betaine (5-AVAB), phenylalanine betaine, and tryptophan
betaine, which are completely absent from bran, were in-
creased significantly. Several betainized compounds, such
as 5-AVAB and alanine betaine, were also observed at
lower levels in the gut tissues (i.e. duodenum, jejunum,
ileum, cecum, and colon) of the GF mice compared to
MPF mice, indicating that the gut microbiota has an im-
pact on their production, although they may also be
acquired from the diet in low amounts. The low level of
5-AVAB in the plasma and its higher levels in the heart,
muscle, and BAT indicate that the compound is rapidly
transported into these metabolically active tissues after ab-
sorption, likely by the cell membrane carnitine transporter
to which 5-AVAB is a substrate [37]. Great variability in
the levels of 5-AVAB, alanine betaine, and TMAO com-
pared to glycine betaine was observed in the gut tissue
samples, which may indicate the microbial origin of these
metabolites and could be explained by the variation in the
gut microbial composition (Additional file 6: Figure S5).
In the in vitro incubation containing microbiota from hu-
man donors, a similar trend was evident, as the level of
glycine betaine decreased while the level of several other
betainized compounds, including 5-AVAB, alanine beta-
ine, and proline betaine, remained constant throughout
the incubation in the rye bran-containing samples while
their levels decreased in the control samples. These find-
ings suggest that components in rye bran may supply the
production of betainized compounds and that glycine
betaine is likely the main source of the metabolites. Fur-
thermore, the results strongly suggest that microbiota
contributes to the production of these compounds, sup-
ported by the location of the metabolism in the gut, the
correlation between the abundance of betainized com-
pounds and the bacterial taxa that were increased by the
bran-enriched diet, and the lowered levels of these com-
pounds in the tissues of the germ-free mice.
Conclusions
We showed that a group of betainized compounds,
which were increased in abundance by dietary cereal
bran, were associated with the composition of gut
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microbiota. According to our findings, bran-enriched
diet can increase the relative abundance of beneficial gut
microbes while decreasing the abundance of bacteria as-
sociated with adverse health effects. At the same time,
the bran acted as a source of glycine betaine, which was
later metabolized into other betainized compounds, a
process likely contributed by the same gut microbes that
were favourably affected by the bran-enriched diet. The
importance of gut microbiota as a mediator of the meta-
bolic effect of diet quality is increasingly highlighted,
and the study presented here brings out yet another
metabolically relevant class of compounds modulated by
the diet and microbiota. Further mechanistic studies
with stable isotope labelled glycine betaine incubated
with selected bacteria are needed to verify the metabolic
pathways of betaines in gut microbiota. In addition, the
potential and mechanism(s) by which betainized com-
pounds maintain the homeostasis and improve health
merit continued investigation.
Methods
Animal experiments
The animal experiments were approved by the Institu-
tional Animal Care and Use Committee of the Provincial
Government of Finland (license number 041003).
C57BL/6 J male mice (n = 74) were obtained from the
National Laboratory Animal Center (Kuopio, Finland) at
the age of 9 weeks and kept under conditions as de-
scribed by Pekkinen et al. [36]. After 1 week of
acclimatization, the mice (n = 64) were fed ad libitum a
commercial high-fat diet (D12451, Research Diets Inc.,
USA) for 9 weeks to induce obesity. Furthermore, one
control group (n = 10) was fed ad libitum a commercial
low-fat control diet (D12450B, Research Diets Inc.,
USA). After 9 weeks of pre-feeding, the mice (except for
the LF group) were randomized into three control and
four study groups (n = 9–14) and fed either with
D12451, D12450B, or HF diets containing the bran en-
richment. The rye bran-enriched diets contained either
unprocessed rye bran (R1) or bioprocessed, i.e. enzymat-
ically treated and yeast fermented rye bran (R2), whereas
the wheat aleurone-enriched diets contained untreated
wheat aleurone (A1) or ground and enzymatically
treated (xylanase and ferulate esterase) aleurone (A4). A
more detailed description of the diets has been pub-
lished previously [36, 61]. The breads were tailor-made
at VTT Technical Research Centre of Finland Ltd, as
described previously [62]. Table 1 shows an overview of
the dietary intervention. After the feeding trial, the mice
were fasted for 8 ± 0.5 h and sacrificed by decapitation
after being made unconscious by CO2 gas. The tissues
and intestinal tissue contents were collected. The tissue
contents were separated from tissues, stored in micro-
centrifuge tubes, and frozen on dry ice. The tissues were
rinsed with physiological saline, wrapped in aluminium
foil, and snap frozen in liquid nitrogen. All samples were
kept at − 80 °C until further processing.
Conventional murine pathogen free (n = 5) and germ-
free (n = 5) C57BL/6NTac male mice aged 10 weeks
were obtained from Taconic Biosciences, Inc. (Hudson,
USA). They were kept on a sterile NIH-31 rodent diet.
Blood was collected and centrifuged at 3000g for 10 min
at room temperature. The 12 other tissue samples
(heart, liver, pancreas, muscle, duodenum, jejunum,
ileum, cecum, colon, VAT, SAT, and BAT) were rinsed
with physiological saline. All tissues were snap-frozen
and kept in − 80 °C until processing for metabolomics
analyses.
Sample processing
Frozen tissue samples were cryo-ground either in 10 ml
grinding steel jars containing a stainless steel ball for 60
s with 15 Hz (liver, subcutaneous adipose tissue) or in 2
ml microcentrifuge tubes containing a 4 or 7 mm stain-
less steel bead in a pre-cooled 2 × 24 adapter that was
shaken for 45 s at 30 Hz (BAT, muscle, heart) using Tis-
sueLyser II (Qiagen Finland, Helsinki, Finland). Samples
containing 100 mg (± 2mg) of tissue powder were cryo-
weighted into 1.5 mL microcentrifuge tubes and 90%
methanol was added (v/v H2O, LC-MS Ultra CHROMA-
SOLV®, Fluka) in a ratio of 300 μL solvent per 100 mg
tissue. The samples were shaken for 20 min. Colon con-
tents were weighed, mixed with 90% methanol (500 μl
methanol per 100 mg content), and shaken with 4-mm
stainless steel beads for 45 s at 20 Hz. All samples were
centrifuged for 10 min at 4 °C (13 000 rpm), and super-
natants were filtered using 0.2 μm Acrodisc® Syringe Fil-
ters with a PTFE membrane (PALL Corporation) and
stored at − 20 °C until the LC–MS analysis. The bread
samples were processed as described previously [62].
Cereal samples and in vitro colonic fermentation
The processed and whole-grain cereal samples were pre-
pared according to Koistinen et al. [62]. The starter used
for the sourdough fermentation contained baker’s yeast
(Candida milleri) 106 cfu/g for whole-grain wheat and
107 cfu/g for whole-grain rye and lactic acid bacteria
(Lactobacillus brevis and Lactobacillus plantarum) 107
cfu/g for whole-grain wheat and 108 cfu/g for whole-
grain rye for both bacterial species. The in vitro upper
intestinal model is described in detail by Aura et al. [63]
and the colonic model by Nordlund et al. [64]. Briefly, to
mimic the digestion in the upper intestinal tract, wheat
breads fortified with native (unprocessed) or biopro-
cessed rye bran were first ground in a mincer (MG450,
Kenwood Ltd, Hampshire, UK) and then exposed to en-
zymatic digestion using porcine enzymes (salivary α-
amylase, pepsin, and pancreatin). The digestion products
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were removed by dialysis, after which the non-digested
residues were freeze-dried and moved into an in vitro
colonic model. A faecal suspension (10% w/v) collected
and pooled from 5 healthy volunteers was used for the
incubation, performed in strictly anoxic conditions. Sam-
ples were taken during the fermentation at time points
0, 2, 4, 6, 8, and 24 h.
LC–MS experiments
The mouse tissue, colon contents, cereal, and in vitro
fermented samples were analyzed by ultra-high-
performance liquid chromatography quadrupole time-
of-flight mass spectrometry (UHPLC–qTOF-MS) system
(Agilent Technologies), consisting of a 1290 LC system,
a Jetstream electrospray ionization (ESI) source, and a
6540 UHD accurate-mass qTOF spectrometer. The
chromatographic separation was performed with hydro-
philic interaction chromatography (HILIC). The sample
tray was kept at + 4 °C during the analysis. The data ac-
quisition software was the MassHunter Acquisition
B.04.00 (Agilent Technologies). During the liquid chro-
matography, 3 μL of the sample solution was injected
onto the column (Acquity UPLC BEH Amide column,
2.1 × 100mm, 1.7 μm; Waters Corporation) and main-
tained at 45 °C. The mobile phases, delivered at 0.6 mL/
min, consisted of 50% acetonitrile (vol:vol; eluent A) and
90% acetonitrile (vol:vol; eluent B), respectively, both
containing 20 mmol/L ammonium formate, pH 3
(Sigma-Aldrich). The following gradient profile was
used: 0–2.5 min, 100% B; 2.5–10 min, 100% B → 0% B;
10–10.1 min, 0% B→ 100% B; 10.1–14min, 100% B.
The MS conditions were as follows: Jetstream ESI source,
operated in positive ionization mode, with a drying gas
temperature of 325 °C and flow of 10 L/min, a sheath gas
temperature of 350 °C and flow of 11 L/min, a nebulizer
pressure of 310 kPa, capillary voltage of 3500 V, nozzle volt-
age of 1000 V, fragmentor voltage of 100 V, and a skimmer
voltage of 45 V. For data acquisition, a 2 GHz extended dy-
namic range mode was used, and the instrument was set to
acquire ions over the m/z range 50–1600. Data were col-
lected in the centroid mode at the acquisition rate of 2.5
spectra/s (i.e. 400ms/spectrum) with an abundance
threshold of 150 counts. QC samples were used for the
automatic data-dependent MS/MS analyses. From every
precursor scan cycle, 4 most abundant ions were selected
for fragmentation. These ions were excluded after 2 prod-
uct ion spectra and released again for fragmentation after a
0.25-min hold. The precursor scan time was based on ion
intensity, ending at 20,000 counts or after 300ms. The
product ion scan time was 300ms. The collision energies
were 10, 20, and 40V in subsequent assays. The continuous
mass axis calibration was performed by monitoring two ref-
erence ions (m/z 121.050873 and m/z 922.009798) from an
infusion solution throughout the assays.
Microbial DNA extraction, 16S ribosomal RNA gene
sequencing, and microbial composition analysis
Total bacterial DNA was extracted using the Max-
well® 16 Total RNA system (Promega) with Stool
Transport and Recovery Buffer (STAR; Roche Diag-
nostics Corporation, Indianapolis, IN). Briefly, 0.15 g
of caecal content sample was homogenized with 0.25
g of sterilized 0.1 mm zirconia beads and three glass
beads (2.5 mm) in 350 μL STAR buffer for 3 min at
5.5 ms. Samples were incubated with shaking at 100
rpm for 15 min at 95 °C and pelleted by 5 min centri-
fugation at 4 °C and 14 000 g. The supernatant was
removed, and the pellets were processed again using
200 μL of fresh STAR buffer. The supernatant was
again removed and pooled and 250 μL was used for
purification with Maxwell® 16 Tissue LEV Total RNA
Purification Kit (AS1220) following manufacturer’s in-
structions. DNA was eluted with 50 μL of DNAse and
RNAse free water (Qiagen, Hilden, Germany). DNA
concentrations were measured with NanoDrop ND-
1000 (NanoDrop® Technologies, Wilmington, DE,
USA) and adjusted to 20 ng/μL with DNAse and
RNAse free water. The V4 region of 16S ribosomal
RNA (rRNA) genes was amplified. PCR reactions
were done in duplicates, each in a total volume of
50 μL and containing 20 ng of template DNA. Each
sample was amplified with a unique barcoded primer
515F-n and 806R-n (10 μM each/reaction), 1× HF
buffer (Finnzymes, Vantaa, Finland), 1 μL dNTP Mix
Table 1 Study groups and the diets of the C57BL/6 J mice in the bran-enriched feed trial
Study group n Week 1–9 Week 10–18
HF 14 HF (D12451) HF (D12451)
HFLF 9 HF (D12451) LF (D12450B)
LF 10 LF (D12450B) LF (D12450B)
R1 11 HF (D12451) D12451 + unprocessed rye bran
R2 10 HF (D12451) D12451 + bioprocessed rye bran
A1 9 HF (D12451) D12451 + unprocessed wheat aleurone
A4 11 HF (D12451) D12451 + bioprocessed wheat aleurone
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(10 mM each, Roche Diagnostics GmbH, Mannheim,
Germany), 1 U Phusion® Hot Start II High Fidelity
DNA Polymerase (Finnzymes, Vantaa, Finland), and
36.5 μL of DNAse and RNAse free water. The amplifi-
cation programme included 30 s initial denaturation
step at 98 °C, following by 25 cycles of denaturation at
98 °C for 10 s, annealing at 56 °C for 10 s, elongation
at 72 °C for 10 s, and a final extension at 72 °C for 7
min. The PCR product presence and size (~ 290 bp)
was confirmed with gel electrophoresis using the
Lonza FlashGel® System (Lonza, Cologne, Germany).
Unique barcode tags (n = 70) were used in each li-
brary and artificial control (Mock) communities were
included, as described previously [65]. PCR products
were purified with HighPrep® PCR kit (MagBio Gen-
omics, Alphen aan den Rijn, Netherlands), and DNA
concentrations were measured with Qubit® dsDNA BR
Assay Kit (Life Technologies, Leusden, Netherlands).
One hundred nanograms of each barcoded sample
was pooled together, the amplicon pool was concen-
trated with HighPrep® PCR kit to 20 μL volume, and
the concentration was measured with Qubit® dsDNA
BR Assay Kit and adjusted to 100 ng/μL final concen-
tration. The libraries were sent for adapter ligation
and HiSeq sequencing (GATC-Biotech, Konstanz,
Germany).
Data analysis
For the betaine metabolites, data processing was done using
Profinder (Agilent Technologies), which enabled manually
picking up peaks associated with the amino acid-derived
betaines from the mass spectrometry data. Betaines were
identified by comparison of retention times and use of tar-
geted MS/MS spectra, which were compared to spectra of
commercial and synthetized chemical standards (4-amino-
butyric acid betaine, 5-AVAB, alanine betaine, glycine beta-
ine, phenylalanine betaine, pipecolic acid betaine, proline
betaine, trigonelline, tryptophan betaine, valine betaine) or
published spectra (other betaines).
For the statistical analysis, we used parametric one-
way ANOVA for comparison between all the diet
groups for the betaine levels, Mann–Whitney U test
for comparison between germ-free and conventional
mice for the organ-specific betaine levels and for pair-
wise comparisons of the relative bacterial abundances
between the diet groups, and Kruskal–Wallis one-way
ANOVA for comparison between relative bacterial
abundances between all diet groups. The α level was
set at 0.05 for all statistical tests. For the microbial
composition analysis, data processing and analysis was
carried out using in-house developed scripts [65]. The
samples were rarefied at 3900 reads prior to the alpha
diversity analyses (Shannon’s index and Simpson
diversity index), which were carried out in QIIME
[66]. To determine the difference between the impact
of control and treatment diets on the relative micro-
bial abundance, we performed ANOSIM analyses in
QIIME using weighted and unweighted UniFrac dis-
tances. The redundancy analyses (RDA) were per-
formed in Canoco5 [67]. In RDA, the variance
between the samples (genus-level relative bacterial
abundance) is explained by environmental variables
(in this case diet and betainized metabolites), which
were fitted to corresponding matrices in the resulting
illustration. PCA was performed in RStudio v. 1.1.447
using in-house scripts. The Pearson correlation be-
tween bacterial taxa and betaines, Kruskal–Wallis
one-way ANOVA, Mann–Whitney U test, and the
fold change analyses between the diet groups were
performed in SPSS 25 (IBM) and plotted with an in-
house R script utilizing ggplot2 package. The micro-
bial abundance heatmap was produced in Multiple
Experiment Viewer v4.9.0. For this purpose, the rela-
tive abundances were first normalized based on the
following formula: x = (x − xrow)/SDrow.
Additional files
Additional file 1: Table S1. Betainized compounds observed in the
current study with their LC–MS 487 identification characteristics and
presence in each studied sample type. In case the compound was 488
detected only as trace in a sample, the identification was based on exact
m/z and retention time. 1 = 489 identified with a reference standard; 2 =
putatively annotated based on publicly available exact m/z 490 and MS/
MS spectra. (DOCX 154 kb)
Additional file 2: Figure S1. Principal component analysis (PCA) and
redundancy analysis (RDA) of the microbial composition (relative
abundance data) from the caecal contents of the C57BL/6J mice, with
the control diet groups (left) and treatment groups (right) treated
separately. The RDA illustrations display 10 best-fitting microbial genera.
(TIF 906 kb)
Additional file 3: Figure S2. Box plots of selected bacterial genera in
the caecal contents of the C57BL/6J mice with significantly different
relative abundances in Kruskal–Wallis one-way ANOVA between all diet
groups. Outliers are marked with a circle (○) and extreme outliers with an
asterisk. (TIF 411 kb)
Additional file 4: Figure S3. The average abundance (as signal
counts) of all the identified betainized compounds in the tissue
samples of GF and MPF mice. The error bars signify an error of 1 SD.
Asterisks based on Mann–Whitney U test between the groups: *p <
0.05; ** p < 0.01; ***p < 0.001. (TIF 1126 kb)
Additional file 5: Figure S4. The levels (as signal counts) of betainized
compounds detected with UHPLC–qTOF-MS in 10 different wheat and
rye samples, including processed (white or sifted, containing only the
endosperm) and whole-grain flour (containing all the edible parts of the
grains in their original proportions), processed and whole-grain breads,
and sourdough fermented breads tailor-made at VTT Technical Research
Centre of Finland. The error bars signify an error of 1 SD. (TIF 592 kb)
Additional file 6: Figure S5. The relative abundance of bacterial phyla in
the caecal contents of the studied C57BL/6J mice, divided into control diet
groups and those fed with the bran-enriched diets. The samples are arranged
in ascending order of the most abundant phylum, Firmicutes, which ranges
from 52% to 93% of the microbial population. (PNG 113 kb)
Koistinen et al. Microbiome           (2019) 7:103 Page 11 of 14
Acknowledgements
The authors would like to thank Ms. Miia Reponen for technical assistance,
Dr Carlos Gomez Gallego for advice regarding the microbial composition
analyses, and MSc Anton Mattsson for assistance with the R scripts.
Authors’ contributions
VMK drafted the manuscript. VMK, OK, IZ, and JJ analyzed the metabolomics
data. KB and HS performed the 16 s rRNA sequencing. VM and NRS prepared
the study diets. AMA performed the in vitro colonic fermentation study. KH
and SA developed and supervised the UPLC–QTOF-MS method used in the
study. KH drafted the manuscript and supervised the work. All authors
critically revised the manuscript. All authors read and approved the final
manuscript.
Funding
This work was financially supported by the Faculty of Health Sciences
(University of Eastern Finland) and by the Academy of Finland.
Availability of data and materials
The datasets analyzed in the current study are available from the B2SHARE data
repository maintained by the European research data infrastructure and service
unit (EUDAT); DOI: 10.23728/b2share.648f1de094d84c40a3b17016b8a870c8. The
scripts used in the processing of 16S rRNA sequencing data are available at
http://github.com/JavierRamiroGarcia/NG-Tax.
Ethics approval and consent to participate
For the in vitro colonic fermentation, the volunteers had given a written
consent for the faecal samples, and the collection and handling of the
samples was performed according to the guidelines of the VTT Ethical
committee.
Consent for publication
Not applicable.
Competing interests
VMK, OK, and KH are affiliated with Afekta Technologies, Ltd. The other
authors declare that they have no competing interests.
Author details
1Institute of Public Health and Clinical Nutrition, University of Eastern Finland,
P.O. Box 1627, FI-70211 Kuopio, Finland. 2Laboratory of Microbiology,
Wageningen University & Research, Stippeneng 4, 6708 WE Wageningen, the
Netherlands. 3JRU Agropolymers Engineering and Emerging Technologies
(IATE 1208), SupAgro-INRA-University of Montpellier-CIRAD, Montpellier
CEDEX 1, France. 4School of Pharmacy, University of Eastern Finland, P.O. Box
1627, FI-70211 Kuopio, Finland. 5VTT Technical Research Centre of Finland,
P.O. Box 1000, Tietotie 2, FI-02044 VTT Espoo, Finland.
Received: 21 December 2018 Accepted: 1 July 2019
References
1. Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E,
Almeida M, Quinquis B, Levenez F, Galleron N. Dietary intervention
impact on gut microbial gene richness. Nature. 2013;500(7464):585–8.
2. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE,
Ling AV, Devlin AS, Varma Y, Fischbach MA. Diet rapidly and reproducibly
alters the human gut microbiome. Nature. 2014;505(7484):559–63.
3. Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G,
Quraishi MN, Kinross J, Smidt H, Tuohy KM, et al. The gut microbiota and
host health: a new clinical frontier. Gut. 2016;65(2):330–9.
4. Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of
human metabolism. Nature. 2016;535(7610):56–64.
5. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota
and host metabolism. Nature. 2012;489(7415):242–9.
6. Carmody RN, Turnbaugh PJ. Host-microbial interactions in the metabolism
of therapeutic and diet-derived xenobiotics. J Clin Inv. 2014;124(10):4173–81.
7. Zhang LS, Davies SS. Microbial metabolism of dietary components to
bioactive metabolites: opportunities for new therapeutic interventions.
Genome Med. 2016;8(1):46.
8. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak
G. Metabolomics analysis reveals large effects of gut microflora on
mammalian blood metabolites. Proc Natl Acad Sci.
2009;106(10):3698–703.
9. Donia MS, Fischbach MA. Small molecules from the human microbiota.
Science. 2015;349(6246):1254766.
10. Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee YS, De Vadder F, Arora T,
Hallen A, Martens E, Björck I, Bäckhed F. Dietary fiber-induced improvement
in glucose metabolism is associated with increased abundance of
Prevotella. Cell Metab. 2015;22(6):971–82.
11. Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS,
Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound
over generations. Nature. 2016;529(7585):212–5.
12. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S,
Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota
revealed by a comparative study in children from Europe and rural Africa.
Proc Natl Acad Sci. 2010;107(33):14691–6.
13. Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC,
Tonstad S, Vatten LJ, Riboli E, Norat T. Whole grain consumption and risk of
cardiovascular disease, cancer, and all cause and cause specific mortality:
systematic review and dose-response meta-analysis of prospective studies.
BMJ. 2016;353:i2716.
14. Chen GC, Tong X, Xu JY, Han SF, Wan ZX, Qin JB, Qin LQ. Whole-grain
intake and total, cardiovascular, and cancer mortality: a systematic review
and meta-analysis of prospective studies. Am J Clin Nutr. 2016;104(1):
164–72.
15. de Munter JSL, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain,
bran, and germ intake and risk of type 2 diabetes: a prospective cohort
study and systematic review. PLoS Med. 2007;4(8):e261.
16. Helnæs A, Kyrø C, Andersen I, Lacoppidan S, Overvad K, Christensen J,
Tjønneland A, Olsen A. Intake of whole grains is associated with lower risk
of myocardial infarction: the Danish Diet, Cancer and Health Cohort. Am J
Clin Nutr. 2016;103(4):999–1007.
17. Schwingshackl L, Schwedhelm C, Hoffmann G, Lampousi AM, Knuppel S,
Iqbal K, Bechthold A, Schlesinger S, Boeing H. Food groups and risk of all-
cause mortality: a systematic review and meta-analysis of prospective
studies. Am J Clin Nutr. 2017;105(6):1462–73.
18. Giacco R, Clemente G, Cipriano D, Luongo D, Viscovo D, Patti L, Di Marino L,
Giacco A, Naviglio D, Bianchi MA. Effects of the regular consumption of
wholemeal wheat foods on cardiovascular risk factors in healthy people.
Nutr Metabol Cardiovasc Dis. 2010;20(3):186–94.
19. Tighe P, Duthie G, Vaughan N, Brittenden J, Simpson WG, Duthie S, Mutch
W, Wahle K, Horgan G, Thies F. Effect of increased consumption of whole-
grain foods on blood pressure and other cardiovascular risk markers in
healthy middle-aged persons: a randomized controlled trial. Am J Clin Nutr.
2010;92(4):733–40.
20. Kristensen M, Toubro S, Jensen MG, Ross AB, Riboldi G, Petronio M, Bugel S,
Tetens I, Astrup A. Whole grain compared with refined wheat decreases the
percentage of body fat following a 12-week, energy-restricted dietary
intervention in postmenopausal women. J Nutr. 2012;142(4):710–6.
21. Magnusdottir OK, Landberg R, Gunnarsdottir I, Cloetens L, Åkesson B,
Rosqvist F, Schwab U, Herzig K-H, Hukkanen J, Savolainen MJ. Whole grain
rye intake, reflected by a biomarker, is associated with favorable blood lipid
outcomes in subjects with the metabolic syndrome–a randomized study.
PloS One. 2014;9(10):e110827.
22. Vitaglione P, Mennella I, Ferracane R, Rivellese AA, Giacco R, Ercolini D,
Gibbons SM, La Storia A, Gilbert JA, Jonnalagadda S, et al. Whole-grain
wheat consumption reduces inflammation in a randomized controlled trial
on overweight and obese subjects with unhealthy dietary and lifestyle
behaviors: role of polyphenols bound to cereal dietary fiber. Am J Clin Nutr.
2015;101(2):251–61.
23. Andersson A, Tengblad S, Karlstrom B, Kamal-Eldin A, Landberg R, Basu S,
Aman P, Vessby B. Whole-grain foods do not affect insulin sensitivity or
markers of lipid peroxidation and inflammation in healthy, moderately
overweight subjects. J Nutr. 2007;137(6):1401–7.
24. Brownlee IA, Moore C, Chatfield M, Richardson DP, Ashby P, Kuznesof SA,
Jebb SA, Seal CJ. Markers of cardiovascular risk are not changed by
increased whole-grain intake: the WHOLEheart study, a randomised,
controlled dietary intervention. Br J Nutr. 2010;104(1):125–34.
25. Costabile A, Klinder A, Fava F, Napolitano A, Fogliano V, Leonard C, Gibson
GR, Tuohy KM. Whole-grain wheat breakfast cereal has a prebiotic effect on
Koistinen et al. Microbiome           (2019) 7:103 Page 12 of 14
the human gut microbiota: a double-blind, placebo-controlled, crossover
study. Br J Nutr. 2008;99(1):110–20.
26. Okarter N, Liu RH. Health benefits of whole grain phytochemicals. Crit Rev
Food Sci Nutr. 2010;50(3):193–208.
27. Fardet A. New hypotheses for the health-protective mechanisms of
whole-grain cereals: what is beyond fibre? Nutr Res Rev. 2010;23(01):
65–134.
28. Lattimer JM, Haub MD. Effects of dietary fiber and its components on
metabolic health. Nutrients. 2010;2(12):1266–89.
29. Naresh Chary V, Kumar D, Vairamani M, Prabhakar S. Characterization of
amino acid-derived betaines by electrospray ionization tandem mass
spectrometry. J Mass Spectrom. 2012;47(1):79–88.
30. Blunden G, Smith BE, Irons MW, Yang M-H, Roch OG, Patel AVJBs, ecology.
Betaines and tertiary sulphonium compounds from 62 species of marine
algae. Biochem Syst Ecol. 1992;20(4):373–88. https://www.sciencedirect.com/
science/article/pii/030519789290050N.
31. Ueland PM, Holm PI, Hustad S. Betaine: a key modulator of one-
carbon metabolism and homocysteine status. Clin Chem Lab Med.
2005;43(10):1069–75.
32. Craig SA. Betaine in human nutrition. Am J Clin Nutr. 2004;80(3):539–49.
33. Allred KF, Yackley KM, Vanamala J, Allred CD. Trigonelline is a novel
phytoestrogen in coffee beans. J Nutr. 2009;139(10):1833–8.
34. Ferrazzano GF, Amato I, Ingenito A, De Natale A, Pollio A. Anti-cariogenic
effects of polyphenols from plant stimulant beverages (cocoa, coffee, tea).
Fitoterapia. 2009;80(5):255–62.
35. Kärkkäinen O, Lankinen MA, Vitale M, Jokkala J, Leppänen J, Koistinen V,
Lehtonen M, Giacco R, Rosa-Sibakov N, Micard V, et al. Diets rich in whole
grains increase betainized compounds associated with glucose metabolism.
Am J Clin Nutr. 2018;108(5):971–9.
36. Pekkinen J, Rosa-Sibakov N, Micard V, Keski-Rahkonen P, Lehtonen M,
Poutanen K, Mykkänen H, Kati H. Amino acid-derived betaines dominate as
urinary markers for rye bran intake in mice fed high-fat diet—a nontargeted
metabolomics study. Mol Nutr Food Res. 2015;59:1550–62.
37. Kärkkäinen O, Tuomainen T, Koistinen V, Tuomainen M, Leppänen J, Laitinen
T, Lehtonen M, Rysä J, Auriola S, Poso A, et al. Whole grain intake associated
molecule 5-aminovaleric acid betaine decreases β-oxidation of fatty acids in
mouse cardiomyocytes. Sci Rep. 2018;8(1):13036.
38. Rosa-Sibakov N, Poutanen K, Micard V. How does wheat grain, bran and
aleurone structure impact their nutritional and technological properties?
Trends Food Sci Technol. 2015;41(2):118–34.
39. Bondia-Pons I, Aura A-M, Vuorela S, Kolehmainen M, Mykkänen H,
Poutanen K. Rye phenolics in nutrition and health. J Cereal Sci. 2009;
49(3):323–36.
40. Anson NM, Selinheimo E, Havenaar R, Aura A-M, Mattila I, Lehtinen P,
Bast A, Poutanen K, Haenen GRMM. Bioprocessing of wheat bran
improves in vitro bioaccessibility and colonic metabolism of phenolic
compounds. J Agric Food Chem. 2009;57(14):6148–55.
41. Al-Waiz M, Mikov M, Mitchell S, Smith R. The exogenous origin of
trimethylamine in the mouse. Metabolism. 1992;41(2):135–6.
42. Ross AB, Zangger A, Guiraud SP. Cereal foods are the major source
of betaine in the Western diet–analysis of betaine and free choline
in cereal foods and updated assessments of betaine intake. Food
Chem. 2014;145:859–65.
43. Hanhineva K, Lankinen MA, Pedret A, Schwab U, Kolehmainen M,
Paananen J, de Mello V, Sola R, Lehtonen M, Poutanen K, et al.
Nontargeted metabolite profiling discriminates diet-specific
biomarkers for consumption of whole grains, fatty fish, and bilberries
in a randomized controlled trial. J Nutr. 2015;145(1):7–17.
44. Mitsuoka T. Bifidobacteria and their role in human health. J Ind
Microbiol. 1990;6(4):263–7.
45. Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger
EO, Kayser BD, Levenez F, Chilloux J, Hoyles L, et al. Akkermansia
muciniphila and improved metabolic health during a dietary
intervention in obesity: relationship with gut microbiome richness
and ecology. Gut. 2016;65(3):426–36.
46. Zhong Y, Marungruang N, Fåk F, Nyman M. Effects of two whole-
grain barley varieties on caecal SCFA, gut microbiota and plasma
inflammatory markers in rats consuming low-and high-fat diets. Br J
Nutr. 2015;113(10):1558–70.
47. Anhe FF, Roy D, Pilon G, Dudonne S, Matamoros S, Varin TV, Garofalo C, Moine Q,
Desjardins Y, Levy E, et al. A polyphenol-rich cranberry extract protects from diet-
induced obesity, insulin resistance and intestinal inflammation in association with
increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2015;
64(6):872–83.
48. Jangi S, Gandhi R, Cox LM, Li N, Von Glehn F, Yan R, Patel B, Mazzola
MA, Liu S, Glanz BL. Alterations of the human gut microbiome in
multiple sclerosis. Nat Commun. 2016;7:12015.
49. Clavel T, Lepage P, Charrier C. The Family Coriobacteriaceae. In:
Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F. (eds)
The Prokaryotes. Springer, Berlin, Heidelberg. 2014. https://doi.org/10.1
007/978-3-642-30138-4_343.
50. Clavel T, Desmarchelier C, Haller D, Gérard P, Rohn S, Lepage P,
Daniel H. Intestinal microbiota in metabolic diseases: from bacterial
community structure and functions to species of pathophysiological
relevance. Gut Microbes. 2014;5(4):544–51.
51. Ze X, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a
keystone species for the degradation of resistant starch in the human
colon. ISME J. 2012;6(8):1535.
52. Zhang C, Zhang M, Pang X, Zhao Y, Wang L, Zhao L. Structural
resilience of the gut microbiota in adult mice under high-fat dietary
perturbations. ISME J. 2012;6(10):1848.
53. Chen YJ, Wu H, Wu SD, Lu N, Wang YT, Liu HN, Dong L, Liu TT, Shen
XZ. Parasutterella, in associated with irritable bowel syndrome and
intestinal chronic inflammation. J Gastroenterol Hepatol. 2018;33:
1844–52. https://doi.org/10.1111/jgh.14281.
54. Fujimura KE, Slusher NA, Cabana MD, Lynch SV. Role of the gut
microbiota in defining human health. Expert Rev Anti Infect Ther.
2010;8(4):435–54.
55. Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S,
Harris HMB, Coakley M, Lakshminarayanan B, O’Sullivan O. Gut
microbiota composition correlates with diet and health in the elderly.
Nature. 2012;488(7410):178.
56. Finegold SM. Desulfovibrio species are potentially important in
regressive autism. Med Hypotheses. 2011;77(2):270–4.
57. Rowan F, Docherty NG, Murphy M, Murphy B, Coffey JC, O’Connell PR:
Desulfovibrio bacterial species are increased in ulcerative colitis. Dis
Colon Rectum 2010, 53(11):1530-1536.
58. Geurts L, Lazarevic V, Derrien M, Everard A, Van Roye M, Knauf C, Valet
P, Girard M, Muccioli GG, François P. Altered gut microbiota and
endocannabinoid system tone in obese and diabetic leptin-resistant
mice: impact on apelin regulation in adipose tissue. Front Microbiol.
2011;2:149.
59. Song H, Wang W, Shen B, Jia H, Hou Z, Chen P, Sun Y. Pretreatment with
probiotic Bifico ameliorates colitis-associated cancer in mice: transcriptome
and gut flora profiling. Cancer Sci. 2018;109(3):666–77.
60. Yuan X, Wang J, Yao H. Feruloyl oligosaccharides stimulate the growth of
Bifidobacterium bifidum. Anaerobe. 2005;11(4):225–9.
61. Rosa NN, Pekkinen J, Zavala K, Fouret G, Korkmaz A, Feillet-Coudray C,
Atalay M, Hanhineva K, Mykkänen H, Poutanen K. Impact of wheat aleurone
structure on metabolic disorders caused by a high-fat diet in mice. J Agric
Food Chem. 2014;62(41):10101–9.
62. Koistinen VM, Mattila O, Katina K, Poutanen K, Aura A-M, Hanhineva K.
Metabolic profiling of sourdough fermented wheat and rye bread. Sci Rep.
2018;8(1):5684.
63. Aura AM, Härkönen H, Fabritius M, Poutanen K. Development of an in vitro
enzymic digestion method for removal of starch and protein and
assessment of its performance using rye and wheat breads. J Cereal Sci.
1999;29(2):139–52.
64. Nordlund E, Aura A-M, Mattila I, Kössö T, Rouau X, Poutanen K. Formation of
phenolic microbial metabolites and short-chain fatty acids from rye, wheat,
and oat bran and their fractions in the metabolical in vitro colon model. J
Agric Food Chem. 2012;60(33):8134–45.
65. Ramiro-Garcia J, Hermes GDA, Giatsis C et al. NG-Tax, a highly accurate and
validated pipeline for analysis of 16S rRNA amplicons from complex biomes
[version 2; peer review: 2 approved, 1 approved with reservations, 1 not
approved]. F1000Research. 2018;5:1791. https://doi.org/10.12688/f1
000research.9227.2.
66. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello
EK, Fierer N, Pena AG, Goodrich JK, Gordon JI. QIIME allows analysis of high-
throughput community sequencing data. Nat Methods. 2010;7(5):335.
67. Lepš J, Šmilauer P. Multivariate analysis of ecological data using CANOCO:
Cambridge university press; 2003.
Koistinen et al. Microbiome           (2019) 7:103 Page 13 of 14
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Koistinen et al. Microbiome           (2019) 7:103 Page 14 of 14
